Hannah Pickard, Petrina Chu, Claire Essex, Emily J. Goddard, Katie Baulcombe, Ben Carter, Rachael Bedford, Tim J. Smith
{"title":"Toddler Screen Use Before Bed and Its Effect on Sleep and Attention","authors":"Hannah Pickard, Petrina Chu, Claire Essex, Emily J. Goddard, Katie Baulcombe, Ben Carter, Rachael Bedford, Tim J. Smith","doi":"10.1001/jamapediatrics.2024.3997","DOIUrl":null,"url":null,"abstract":"ImportanceToddler screen time has been associated with poorer sleep and differences in attention. Understanding the causal impact of screen time on early development is of the highest importance.ObjectiveTo test (1) the feasibility of the 7-week parent-administered screen time intervention (PASTI) in toddlers (aged 16-30 months) who have screen time in the hour before bed and (2) the impact of PASTI on toddlers’ sleep and attention.Design, Setting, and ParticipantsThis assessor-blinded, UK-based randomized clinical trial was conducted between July 2022 and July 2023. This was a single-site study that enrolled families with a toddler aged between 16 and 30 months, living within 75 miles of the Babylab, and with 10 minutes or more of screen time in the hour before bed on 3 or more days a week. Exclusion criteria were (1) a genetic or neurological condition, (2) premature birth (&amp;lt;37 weeks), and (3) current participation in another study.InterventionsFamilies were randomized (1:1:1) to (1) PASTI: caregivers removed toddler screen time in the hour before bed and used activities from a bedtime box instead (eg, reading, puzzles); (2) bedtime box (BB only): used matched before-bed activities, with no mention of screen time; or (3) no intervention (NI): continued as usual.Main Outcomes and MeasuresFeasibility outcomes: participation rate, intervention adherence, retention, family experiences, and assessment acceptability. Efficacy outcomes: screen use, actigraphy-measured sleep, and eye-tracking attention measures.ResultsA total of 427 families were screened, 164 were eligible (38.4%), and 105 families were randomized (mean [SD] age, 23.7 [4.6] months; 60 male [57%]). The trial was feasible, with 99% participant (104 of 105) retention and 94% of families (33 of 35) adhering to PASTI. PASTI showed reductions in parent-reported screen time (vs NI: Cohen <jats:italic>d</jats:italic> = −0.96; 95% CI, −1.32 to −0.60; vs BB only: Cohen <jats:italic>d</jats:italic> = −0.65; 95% CI, −1.03 to −0.27). PASTI showed small to medium improvements in objectively measured sleep efficiency (vs NI: Cohen <jats:italic>d</jats:italic> = 0.27; 95% CI, −0.11 to 0.66; vs BB only: Cohen <jats:italic>d</jats:italic> = 0.56; 95% CI, 0.17-0.96), night awakenings (vs NI: Cohen <jats:italic>d </jats:italic>= −0.28; 95% CI, −0.67 to 0.12; vs BB only: Cohen <jats:italic>d</jats:italic> = −0.31; 95% CI, −0.71 to 0.10), and reduced daytime sleep (vs NI: Cohen <jats:italic>d </jats:italic>= −0.30; 95% CI, −0.74 to 0.13) but no difference compared with BB only. There was no observable effect of PASTI on objective measures of attention. Compared with BB only, PASTI showed a difference on parent-reported effortful control (Cohen <jats:italic>d</jats:italic> = −0.40; 95% CI, −0.75 to −0.05) and inhibitory control (Cohen <jats:italic>d</jats:italic> = −0.48; 95% CI, −0.77 to −0.19), due to an increase in BB-only scores.Conclusions and RelevanceResults of this randomized clinical trial show that, supporting pediatric recommendations, removing screen time before toddler bedtime was feasible and showed modest preliminary beneficial effects on sleep. A future full confirmatory trial is needed before PASTI’s adoption by parents and pediatricians.Trial RegistrationISRCTN.org Identifier: <jats:ext-link xmlns:xlink=\"http://www.w3.org/1999/xlink\" ext-link-type=\"uri\" xlink:href=\"https://doi.org/10.1186/ISRCTN58249751\">ISRCTN58249751</jats:ext-link>","PeriodicalId":14683,"journal":{"name":"JAMA Pediatrics","volume":"12 1","pages":""},"PeriodicalIF":24.7000,"publicationDate":"2024-10-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"JAMA Pediatrics","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1001/jamapediatrics.2024.3997","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"PEDIATRICS","Score":null,"Total":0}
引用次数: 0
Abstract
ImportanceToddler screen time has been associated with poorer sleep and differences in attention. Understanding the causal impact of screen time on early development is of the highest importance.ObjectiveTo test (1) the feasibility of the 7-week parent-administered screen time intervention (PASTI) in toddlers (aged 16-30 months) who have screen time in the hour before bed and (2) the impact of PASTI on toddlers’ sleep and attention.Design, Setting, and ParticipantsThis assessor-blinded, UK-based randomized clinical trial was conducted between July 2022 and July 2023. This was a single-site study that enrolled families with a toddler aged between 16 and 30 months, living within 75 miles of the Babylab, and with 10 minutes or more of screen time in the hour before bed on 3 or more days a week. Exclusion criteria were (1) a genetic or neurological condition, (2) premature birth (&lt;37 weeks), and (3) current participation in another study.InterventionsFamilies were randomized (1:1:1) to (1) PASTI: caregivers removed toddler screen time in the hour before bed and used activities from a bedtime box instead (eg, reading, puzzles); (2) bedtime box (BB only): used matched before-bed activities, with no mention of screen time; or (3) no intervention (NI): continued as usual.Main Outcomes and MeasuresFeasibility outcomes: participation rate, intervention adherence, retention, family experiences, and assessment acceptability. Efficacy outcomes: screen use, actigraphy-measured sleep, and eye-tracking attention measures.ResultsA total of 427 families were screened, 164 were eligible (38.4%), and 105 families were randomized (mean [SD] age, 23.7 [4.6] months; 60 male [57%]). The trial was feasible, with 99% participant (104 of 105) retention and 94% of families (33 of 35) adhering to PASTI. PASTI showed reductions in parent-reported screen time (vs NI: Cohen d = −0.96; 95% CI, −1.32 to −0.60; vs BB only: Cohen d = −0.65; 95% CI, −1.03 to −0.27). PASTI showed small to medium improvements in objectively measured sleep efficiency (vs NI: Cohen d = 0.27; 95% CI, −0.11 to 0.66; vs BB only: Cohen d = 0.56; 95% CI, 0.17-0.96), night awakenings (vs NI: Cohen d = −0.28; 95% CI, −0.67 to 0.12; vs BB only: Cohen d = −0.31; 95% CI, −0.71 to 0.10), and reduced daytime sleep (vs NI: Cohen d = −0.30; 95% CI, −0.74 to 0.13) but no difference compared with BB only. There was no observable effect of PASTI on objective measures of attention. Compared with BB only, PASTI showed a difference on parent-reported effortful control (Cohen d = −0.40; 95% CI, −0.75 to −0.05) and inhibitory control (Cohen d = −0.48; 95% CI, −0.77 to −0.19), due to an increase in BB-only scores.Conclusions and RelevanceResults of this randomized clinical trial show that, supporting pediatric recommendations, removing screen time before toddler bedtime was feasible and showed modest preliminary beneficial effects on sleep. A future full confirmatory trial is needed before PASTI’s adoption by parents and pediatricians.Trial RegistrationISRCTN.org Identifier: ISRCTN58249751
期刊介绍:
JAMA Pediatrics, the oldest continuously published pediatric journal in the US since 1911, is an international peer-reviewed publication and a part of the JAMA Network. Published weekly online and in 12 issues annually, it garners over 8.4 million article views and downloads yearly. All research articles become freely accessible online after 12 months without any author fees, and through the WHO's HINARI program, the online version is accessible to institutions in developing countries.
With a focus on advancing the health of infants, children, and adolescents, JAMA Pediatrics serves as a platform for discussing crucial issues and policies in child and adolescent health care. Leveraging the latest technology, it ensures timely access to information for its readers worldwide.